Fusarielin A (FSA), isolated from culture of Fusarium sp. K432, has anti-fungal/anti-angiogenic activity. Based on our previous structure-activity relationship studies, we prepared FSA-immobilized affinity gel. The results of affinity chromatography with this gel indicated that tubulin and actin are FSA-binding proteins. The binding affinities of tubulin and actin for FSA were estimated by the use of surface plasmon resonance spectroscopy.
Fusarielin A (1: FSA, Fig. 1 ) is an anti-fungal/anti-angiogenic/anti-proliferative natural product isolated from culture of Fusarium sp. K432. For the isolation of FSA, we applied the Pyricularia oryzae (P. oryzae) P-2b assay method based on the germination of conidia. [1] [2] [3] The germination process is sensitive to various kinds of bioactive compounds (details will be published elsewhere). 3) In particular, tubulin polymerization inhibitors, including rhizoxin, 4) griseofulvin, 5) nocodazole 6) and phomopsidin, 7) generally induce clear morphological effects, such as curling, in mycelia resulting from germination of the conidia. FSA induced similar morphological changes to the above tubulin polymerization inhibitors, suggesting that it may exert its biological activities through binding to tubulin and affecting tubulin function. 1, 2) However, FSA was found not to inhibit the polymerization/depolymerization of tubulin in typical assays using porcine tubulin protein fractions. [1] [2] [3] Thus, the target molecule(s) and mechanism of action of FSA both remain to be clarified. 3) Our previous structure-activity relationship (SAR) studies suggested that the 1-hydroxyl group, the 11,12-epoxy group and the 15,16-epoxy group of FSA are mandatory for the anti-fungal, anti-angiogenic and antiproliferative activities. In contrast, benzylation of the 3-hydroxyl group of FSA (1) does not affect these activities. Based on these results, we designed and prepared a photoaffinity labeling agent, CAFSA (coumarin-and azidophenyl-substituted FSA derivative, 2, Fig. 1 ), which showed the same biological activities as FSA. 3) By using CAFSA and tritium-labeled FSA (prepared biosynthetically), cellular uptake, cytosolic distribution, and the likely presence of specific binding protein(s) of FSA (1) have been demonstrated.
3) Here, we planned to identify the FSAspecific binding protein(s) by using FSA-immobilized affinity gel.
In this paper, we describe (i) the design and preparation of the affinity gel, (ii) the identification of actin and tubulin as FSA-specific binding proteins by the use of the prepared affinity gel, and (iii) direct investigation of the binding affinity of actin and tubulin for FSA (1) using surface plasmon resonance (SPR) spectroscopy.
Results and Discussion
Preparation of Affinity Gels for the Isolation of FSABinding Proteins Previously, we showed that CAFSA (2) possesses anti-angiogenic activity [inhibition of tube formation of human umbilical vein endothelial cells (HUVEC)] and anti-proliferative activity (growth inhibition of human leukemia HL-60 cells) with similar potency to FSA (1). 3) This led us to design and prepare ZAFSA-Gel (7: Chart 1), i.e., FSA (1) coupled with Affi-Gel 10 (Bio-Rad, Ltd.), a commercially available agarose having surface N-hydroxysuccinimide ester groups for the immobilization of primaryamine-containing compounds.
As shown in Chart 1, a spacer moiety containing primary amine was introduced at the 3-hydroxyl group of FSA, and the resulting ligand, named ZAFSA (6; Chart 1), was coupled with Affi-Gel 10 by use of the method previously reported. 7, 8) Briefly, the primary alcoholic group (the 1-hydroxyl group) of FSA (1) was protected with a tert-butyldimethylsilyl (TBS) group, followed by introduction of a tert-buthoxylcarbonylmethine group at the 3-hydroxyl group to afford 4. Then, the tert-butyl ester moiety of 4 was hydrolyzed, followed by coupling with ethylenediamine in the presence of carbonyldiimidazole (CDI) to give 5. Deprotection of 5 using tetra-n-butylammonium fluoride (TBAF) gave ZAFSA (6) , and then ZAFSA (6) was coupled with Affi-Gel 10. Unreacted activated ester groups on the gel were quenched by addition of an excess amount of ethanolamine to give ZAFSA-Gel (7) . The efficacy of the coupling reaction was estimated by measuring the amount of free ZAFSA (6) remaining in the reaction mixture. Under typical reaction conditions, ZAFSA-Gel (7) bears 5-10 mmol ZAFSA/ml gel bed volume. In the experiments described in this paper, ZAFSA-Gel (7) with 8.7 mmol ZAFSA/ml gel bed volume was used. To confirm the effectiveness of the designed ligand Fig. 2) , the N-benzoyl derivative of ZAFSA, was prepared and tested for biological activities. It was confirmed to show anti-angiogenic and anti-proliferative activities (measured by means of previously reported methods 3) ) with similar potency to FSA ( Table 1 ), indicating that ZAFSA-Gel should be suitable to purify FSA-binding proteins.
Identification of Binding Proteins of Fusarielin A as Actin and Tubulin
In contrast, the 11,12-epoxy group of FSA (1) is essential for potent biological activities; hydrolysis of this group resulted in a dramatic decrease of the biological activities of FSA (1), especially anti-proliferative activity, though moderate anti-angiogenic activity remained.
1-3) Therefore, we also designed and prepared DAFSA-Gel (10) as a negative control gel by the method shown in Chart 2. Briefly, nucleophilic attack of ethylenediamine in methanol toward FSA (1) occurred selectively at the 11-position to give DAFSA (9), which was used as a substrate for coupling with Affi-Gel 10 (Chart 2). As expected, DAFSA (9) showed only very weak anti-proliferative activity toward HL-60 cells (IC 50 value of Ͼ100 mM; growth was inhibited by only 24% at 100 mM concentration) and moderate anti-angiogenic activity measured by assay of HUVEC tube formation-inhibitory activity (Table  1) , indicating the suitability of DAFSA-Gel as a negative control gel.
Finally, to identify nonspecifically binding proteins, AffiGel 10 was reacted with an excess of ethanolamine, and the resulting spacer-bearing gel was used as a control gel.
Purification and Identification of FSA-Binding Proteins Our previous studies using HL-60 cells and tritiumlabeled FSA showed that FSA (1) taken up in HL-60 cells is distributed into the cytosolic fraction.
3) Therefore, the cytosolic fraction prepared from HL-60 cells was used as a source to search for FSA-binding proteins.
Briefly, cytosolic fraction prepared from HL-60 cells was incubated with control gel, ZAFSA-Gel (7), or DAFSA-Gel (10), then washed with phosphate-buffered saline (PBS). The washed gels were treated with hot sodium dodecylsulfate (SDS) solution to elute proteins absorbed on the gels, if any. The supernatant was separated and analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and separated proteins were stained with Coomassie Brilliant Blue (CBB).
Two bands at around 50 kDa (one major and one minor, indicated by arrows in Fig. 3 , lane B) were detected only in the eluate from ZAFSA-Gel (7) . No such bands were observed in the eluate from the control gel (Fig. 3, lane A) . In the case of the eluate from DAFSA-Gel (10), the bands were not detected under the same staining conditions, but prolonged staining of the gel resulted in visualization of a weak band Table 1 . Anti-angiogenic and Anti-proliferative Activities of FSA (1), 8 and DAFSA (9) FSA ( Chart 1 (Fig. 3 , lane C) which seems to correspond to the major band in lane B. Moreover, when the ZAFSA-Gel (7) incubated with HL-60 cytosolic fraction was eluted with an excess amount of FSA (1)-containing solution, these two bands became weaker, suggesting that they represent FSA-selective/ specific binding proteins.
Although we used DAFSA-Gel (10) as a negative control gel, DAFSA (10) shows weak biological activity (i.e., it is not completely inactive), as shown in Table 1 , so the detection of a weak band in lane C corresponding to the major band in lane B is not problematic.
Next, the two bands detected in lane B (Fig. 3) were excised, subjected to in-gel digestion with trypsin, and analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MASS). By using the Mascot online database searching algorithm, these two bands were identified as tubulin beta and ACTB protein (beta actin), respectively ( Table 2) .
Detection of Direct Binding of FSA (1) with Actin/ Tubulin and Determination of Quantitative Binding Parameters by Surface Plasmon Resonance (SPR) Spectroscopy As described above, tubulin and actin were identified as candidate FSA (1)-binding proteins. To verify that FSA (1) really binds to tubulin and/or actin, we directly examined the interaction between FSA (1) and tubulin/ actin using SPR spectroscopy. For this purpose, tubulin (isolated/purified from porcine brain) and actin (from rabbit skeletal muscle, Cytoskeleton Inc., Denver, CO, U.S.A.) were immobilized on the carboxymethylated dextran surface of a CM5 sensor chip for SPR analysis using a Biacore T100 (GE Healthcare). We have previously established that the binding of small molecules, including colchicine and 5HPP-33 (both of which are potent tubulin polymerization inhibitors), to tubulin can be detected by this method. , respectively. These values are consistent with the concentrations at which FSA elicits its biological activities, considering that both actin and tubulin are polymeric macromolecules. These results indicate that actin and/or tubulin are likely to be target protein(s) of FSA. However, it has been reported that FSA does not affect the polymerization/depolymerization of tubulin, as far as investigated for porcine tubulin with a typical turbidity assay.
1-3)
Determination of the Effects of FSA (1) on Cellular Morphology and Actin Filaments by Using Cytohistochemical Analysis To further examine the effects of FSA on actin, we investigated the FSA-induced morphological changes of human embryonic kidney cell line HEK-293. Morphological changes were observed in both optical microscopic (cell shape) and cytohistochemical fluorescence (actin filament morphology) analyses using actin-staining phalloidin-fluorescein isothiocyanate (FITC) (Fig. 4) . Optical microscopy (upper panels, Fig. 4) showed that cells treated with FSA (1) became round, as is observed in cells treated with a typical actin-polymerization inhibitor, cytochalasin B. However, actin filaments showed different morphological changes in FSA-treated cells (lower panels, Fig. 4 ) than in cytochalasin B-treated cells (Fig. 4) . These results indicate that FSA may affect cell mobility and extension, but its effects on actin-polymerization are unclear. To evaluate the effects of FSA on actin polymerization, rat embryonal vascular smooth muscle cell line A7r5 was employed. 10, 11) The filamentous actin (F-actin) of A7r5 cells could be clearly visualized by means of phalloidin-FITC staining. As shown in Fig. 5 , no disruption of actin filaments was observed in FSA (1)-treated cells, suggesting that FSA (1) does not inhibit actin polymerization.
Cytohistochemical fluorescence analysis using anti-atubulin/FITC conjugate was also performed using HeLa cells (Fig. 6 ). Although FSA (1) does not inhibit the polymerization/depolymerization of tubulin (as far as investigated with typical tubulin polymerization/depolymerization assay methods using porcine tubulin protein fractions), [1] [2] [3] the morphology in FSA (1)-treated cells seemed to be different from that in non-treated cells, and closer to those in cells treated with typical tubulin disruptors, including colchicine and taxol (Fig. 6) .
One possible interpretation is that actin and/or tubulin is a target molecule(s) of FSA (1), but the effect(s) of FSA (1) on the function(s) of actin and/or tubulin is different from that of typical known actin-or tubulin-polymerization/depolymerization inhibitors. Cytohistochemical staining revealed disruption of pseudopodium and a rounded cell shape, indicating that FSA (1) may influence cell mobility, which is controlled by the cytoskeleton. Some proteins, such as spectrin 12) or raft-associated proteins, 13) were reported to control the cell morphology and mobility by modulating the interaction between cell membrane and cytoskeleton, and FSA (1) might disrupt these interactions.
The anti-angiogenic activity of FSA (1) could be caused by such effects. Another possibility is that the effects of FSA (1) binding to actin and/or tubulin are cell type-specific. Of course, it is also possible that the bindings of FSA (1) to actin and tubulin are unrelated to the biological activities elicited by FSA (1), but this seems implausible, considering that the K a values for the FSA (1)/actin and FSA (1)/tubulin interactions are consistent with the biologically effective concentration range of FSA (1).
Conclusion
Actin and tubulin were identified as FSA (1)-binding proteins. Although the biological meanings of these interactions remain to be established, the binding affinities of actin and 
Experimental
Preparation of FSA (1) FSA from Fusarium sp. K432 was purified using the reported method. [1] [2] [3] Briefly, Fusarium sp. K432 strain was cultured in dishes each containing 30 ml of potato dextrose medium (potato 200 g, dextrose 20 g per liter of water) at 20°C for 21 d. The acetone-benzene extract of a total of 2.4 l of culture was separated by silica gel column chromatography. The column was eluted with ethyl acetate-hexane (3 : 2). The eluate was concentrated, and the residue (2.8 g) was subjected to Sephadex LH-20 column chromatography, eluted with MeOH. The eluate was concentrated, and the residue was applied to a column of activated charcoal. This column was eluted with MeOH, and the eluate was concentrated to give FSA (1) as a white powder (550 mg).
1-(tert-Butyldimethylsilyloxy)-FSA (3)
To a solution of FSA (1) 
1-(tert-Butyldimethylsilyloxy)-3-(tert-butoxycarbonylmethyl)-FSA (4)
To a solution of 3 (4.0 mg, 7.7 mmol) in toluene (45 ml) were added tetran-butylammonium bromide (0.8 mg, 2.5 mmol), tert-butyl bromoacetate (4.0 ml, 24.8 mmol), 12 N NaOH (30 ml, 360 mmol), and the mixture was stirred for 40 h at room temperature. The reaction was quenched by addition of brine and the mixture was extracted with Et 2 O, and concentrated under reduced pressure. The product was purified by silica-gel column chromatography (hexane/ethyl acetateϭ19/1, 9/1 to 6/1) to give 4 (2.3 mg, 3.6 mmol, 47%) as a colorless oil; 
1-(tert-Butyldimethylsilyloxy)-3-(aminoethylaminocarbonylmethyl)-FSA (5)
To a solution of 4 (25.1 mg, 39.8 mmol) in a 1 : 5 mixture of THF and methanol (0.6 ml) was added 2 N NaOH (80 ml, 160 mmol), and the mixture was stirred for 42 h at room temperature. The reaction was quenched by adding 1 N HCl to make pH 7 and the mixture was extracted with Et 2 O. The organic solution was concentrated under reduced pressure. To the residue was added a solution of 1,1Ј-carbonyldiimidazole (9.4 mg, 58.0 mmol) in DMF (0.2 ml) and the mixture was stirred at room temperature. After 30 min, ethylenediamine (13 ml, 194 mmol) was added, and stirring was continued for 65 h at the same temperature. The reaction was quenched by addition of brine and the mixture was extracted with Et 2 O. The organic solution was concentrated under reduced pressure. The product was purified by silica-gel column chromatography (CH 2 Preparation of Affinity Gels: Control Gel, ZAFSA-Gel (7) and DAFSA-Gel (10) Commercially available Affi-Gel 10 (Bio-Rad, Ltd.) was washed with isopropanol using a filtration apparatus under reduced pressure. Then, the gel (2 ml bed volume) was suspended in isopropanol (2 ml) and to this was added 0.3 mmol of ethanolamine (for control gel), 0.03 mmol of ZAFSA (6) [for ZAFSA-gel (7)] or 0.03 mmol of DAFSA (9) [for DAFSAgel (10)] in 2 ml of isopropanol. The mixture was incubated at room temperature for 6 h under gentle stirring. For ZAFSA-and DAFSA-gel, 0.3 mmol of ethanolamine was added and incubation was continued at room temperature for an additional 6 h. Then the gel was collected by filtration under reduced pressure, washed with isopropanol 6 times using a filtration apparatus, and resuspended in 2 ml of isopropanol. This stock suspension was stored in a refrigerator (Ϫ20°C). DAFSA: 11-(Aminoethylaminocarbonylmethyl)-FSA (9) To a solution of FSA (1) (20 mg, 0.050 mmol) in MeOH (0.1 ml) was added ethylenediamine anhydrous (1.25 ml in 1 ml MeOH, 0.187 mmol) and the mixture was stirred at 50°C for 7 d. The reaction was quenched by adding H 2 O and the mixture was extracted with ethyl acetate. The organic solution was dried (MgSO 4 ), and concentrated under reduced pressure to give DAFSA (9) (10.8 mg, 0.023 mmol, 47%) as a white powder; Purification and Identification of FSA (1)-Binding Proteins by the Use of ZAFSA-Gel (7) HL-60 cells, maintained in RPMI1640 medium supplemented with 10% v/v fetal bovine serum (FBS), were collected by centrifugation at 2000 rpm for 10 min at 4°C. The cell pellet was treated with 20 mM Tris-HCl (pH 7.6) for 45 min on ice. Then, the mixture was centrifuged at 105000 g for 1 h at 4°C, and the supernatant was collected and used as cytosolic fraction. The protein concentration was adjusted to 1.0 mg/ml in PBS, and the solution (1.3 ml) was incubated with ZAFSA-gel (7, bed volume of 40 ml) at 4°C for 1 h. The mixture was centrifuged at 15000 rpm for 1 min, and the gel pellet was collected and washed. Then, SDS-PAGE sample loading buffer 10 ml was added to the gel pellet, and boiled at 100°C for 5 min. The resulting mixture was analyzed by SDS-PAGE. Bands were cut from the ZAFSA-gel and subjected to in-gel digestion with trypsin according to the general protocol. Then, the mixture of peptides was extracted from each band and analyzed by MALDI-TOF Mass (Bruker, Microflex), using Mascot online database search (Bruker, Biotool software).
Preparation of Tubulin Microtubule protein was prepared from porcine brain as described.
14-16) Pure tubulin dimer was obtained by ion-ex-
